The MultiTEP strategy provides a unique opportunity to generate high levels of antibodies in the elderly by activating not only naïve Th cells, but also pre-existing memory Th cells previously generated in response to infections and/or vaccinations with tetanus toxin, hepatitis B, and influenza, thereby overcoming immunosenescence. The gene discussed is PPIB; the disease is Hepatitis.